CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $42.2M, above the global median of $16.24M
- FinancialsAltman Z-Score 0.28: distress zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.36BCNY350.46M · vs all stocks (USD)
Revenue (TTM)
710.14MCNY105.61M · vs all stocks (USD)
Profit Margin
-47.97%Beta
0.3260xvs all stocks
52-Week Change
-36.75%vs all stocks
Market Capitalization
2.36BCNY350.46M · vs all stocks (USD)
Enterprise Value
3.51BCNY521.59M · vs all stocks (USD)
Price to Sales (TTM)
3.32xPrice to Book (MRQ)
6.14xEnterprise to Revenue
4.94xEnterprise to EBITDA
-18.87xGross Margin
25.12%Profit Margin
-47.97%Operating Margin
-8.03%Return on Assets (TTM)
-6.45%Return on Equity (TTM)
-56.33%Revenue (TTM)
710.14MCNY105.61M · vs all stocks (USD)
Revenue per Share (TTM)
1.77CNYUpdated Aug 21, 2026Quarterly Revenue Growth
-56.60%Gross Profit (TTM)
149.27MCNY22.20M · vs all stocks (USD)
EBITDA (TTM)
-185.90MCNY-27.65M · vs all stocks (USD)
Net Income (TTM)
-340.68MCNY-50.66M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-61.64%Operating Cash Flow (TTM)
297.36MCNY44.22M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
283.76MCNY42.20M · vs all stocks (USD)
Payout Ratio
0.00%Minority Interest (Equity)
45.32MCNYFY2025 · Dec 31, 2025Revenue
900.84MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
636.47MCNYFY2025 · Dec 31, 2025Gross Profit
264.37MCNYFY2025 · Dec 31, 2025Operating Income
-159.76MCNY-23.76M · vs all stocks (USD)
Pre-tax Income
-268.67MCNYFY2025 · Dec 31, 2025Income Tax Expense
15.66MCNYFY2025 · Dec 31, 2025Net Income
-284.33MCNYFY2025 · Dec 31, 2025EBIT
-227.92MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-71.09MCNYFY2025 · Dec 31, 2025Research & Development
93.86MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
198.80MCNYFY2025 · Dec 31, 2025Other Operating Expenses
15.04MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
496.18KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
40.75MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.7200CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.7200CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
399.13MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
399.13MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-284.33MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-3.05MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-126.22MCNYFY2025 · Dec 31, 2025Free Cash Flow
-209.88MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
63.12MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-284.33MCNYFY2025 · Dec 31, 2025Other Non-cash Items
42.09MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-50.56MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
166.57MCNYFY2025 · Dec 31, 2025Capital Expenditures
-83.66MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-83.66MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
426.40MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-636.56MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-33.55MCNYFY2025 · Dec 31, 2025Other Financing Charges
2.48MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-241.25MCNYFY2025 · Dec 31, 2025Shares Outstanding
400.11MSharesUpdated Aug 21, 2026Float Shares
171.88MSharesUpdated Aug 21, 2026% Held by Insiders
76.62%vs all stocks
% Held by Institutions
0.00%vs all stocks
Total Cash (MRQ)
76.57MCNY11.39M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.1910CNYUpdated Aug 21, 2026Total Debt (MRQ)
1.18BCNY175.71M · vs all stocks (USD)
Total Debt to Equity (MRQ)
2.75xCurrent Ratio (MRQ)
0.6260xBook Value per Share (MRQ)
0.9590CNYUpdated Aug 21, 2026Total Assets
2.60BCNY387.09M · vs all stocks (USD)
Total Current Assets
881.30MCNYFY2025 · Dec 31, 2025Total Liabilities
2.14BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.72BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
703.54MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.44BCNYFY2025 · Dec 31, 2025Cash
64.93MCNYFY2025 · Dec 31, 2025Cash Equivalents
13.28MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
78.21MCNYFY2025 · Dec 31, 2025Accounts Receivable
418.01MCNYFY2025 · Dec 31, 2025Inventory
254.34MCNYFY2025 · Dec 31, 2025Accounts Payable
539.97MCNYFY2025 · Dec 31, 2025Short-term Debt
626.01MCNYFY2025 · Dec 31, 2025Other Current Liabilities
9.70MCNYFY2025 · Dec 31, 2025Long-term Debt
546.63MCNYFY2025 · Dec 31, 2025Common Stock (Book)
400.11MCNYFY2025 · Dec 31, 2025Retained Earnings
-335.91MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
458.02MCNY68.11M · vs all stocks (USD)
52-Week Low
5.15CNYUpdated Aug 21, 202652-Week High
10.37CNYUpdated Aug 21, 202652-Week Change
-36.75%vs all stocks
Beta
0.3260xvs all stocks
50-Day MA
5.85CNYUpdated Aug 21, 2026200-Day MA
7.01CNYUpdated Aug 21, 2026Avg 10-Day Volume
1.56MSharesUpdated Aug 21, 2026Avg 30-Day Volume
1.94MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
-0.8600CNYUpdated Aug 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 0.28: distress zoneCritical
Altman Z-Score: 0.28
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $42.2M, above the global median of $16.24MNotable
Levered free cash flow (USD): 42,198,644.373Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Standard Biotools Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Zhenyuan Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
Deva Holding A.S.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Bionote Inc.
Tier 1ProductionApproval-Gated PipelineRule
Suzhou Fushilai Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
Cellectis S.A.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Zhejiang Tailin Bioengineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shandong Sito Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang East-Asia Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Zhejiang Xinguang Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Ch. Karnchang Public Company Limited
1 interpretationWithin or Near the Altman Distress Zone
Shandong Longda Meishi Co., Ltd.
1 interpretationWithin or Near the Altman Distress Zone
China High-Speed Railway Co., Ltd.
1 interpretationWithin or Near the Altman Distress Zone